4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-16-006881
Options or other derivatives
- CEO, PRESIDENT acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Jaksch Frank L Jr · CEO, PRESIDENT
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-08-15 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +85,000 | 85,000 | D |
Loading xslF345X03/form4-08172016_010831.xml…